KDIGO指南制定生命周期系列第一部分:新系列介绍
本文是KDIGO指南制定生命周期7篇系列文章的第一篇,介绍KDIGO指南制定流程并总结其不同产品与交付物。文章指出肾脏病已成为全球公共卫生优先事项,KDIGO持续致力于以最佳证据为基础、透明包容地制定可信赖指南。
要点
- WHO通过首个肾脏健康决议,确立肾脏病为全球公共卫生优先事项。
- 本文介绍KDIGO指南制定流程及各类产品与交付物。
核心结论
- KDIGO通过透明、包容和诚信的流程制定可信赖的肾脏病指南,并持续适应快速变化的环境。
研究设计与样本
- 本文为KDIGO指南制定生命周期7篇系列文章的第一篇,介绍指南制定流程并总结KDIGO产品与交付物。
主要发现
- 肾脏病已被确立为全球公共卫生优先事项,世界卫生组织通过了首个聚焦肾脏健康的决议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The medical community has long recognized the role of kidney disease and its impact on overall health. This recognition was accompanied by acknowledging the need for guidelines that help standardize practice based on the best available evidence. More recently, kidney disease has been established as a global public health priority when the World Health Organization adopted the first-ever resolution focused on kidney health. Kidney Disease: Improving Global Outcomes (KDIGO) was established, more than 2 decades ago, to address this need. As KDIGO adapts its processes to meet the needs of a rapidly changing landscape, its strong commitment to transparency, inclusivity, and integrity in developing trustworthy guidelines based on the best available evidence persists. In this 7-article series about the KDIGO life cycle of guideline development, we highlight a few aspects in the KDIGO guideline process. We also address areas that are frequently asked about by KDIGO end users and stakeholders (also known as interest holders). In this first article, we introduce the KDIGO guideline development process and summarize the different KDIGO products and deliverables.
引用
- Mustafa RA, Earley A, Oliveras L, et al. Kidney Disease: Improving Global Outcomes (KDIGO) life cycle of guideline development series: part 1: introduction to a new series. Kidney Int. 2026. PMID: 42248560. doi:10.1016/j.kint.2026.02.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。